Director, Global Value & Evidence
Pfizer, Inc.
Disclosure(s): Pfizer Inc.: Employee, Stocks/Bonds (Public Company)
Amy Law, PharmD, is Director at Health Economics and Outcomes Research (HEOR) group in Pfizer, Inc., based in New York City. She has over 20 years working in pharmaceutical industry and devoted the past 3 years supporting RSV maternal vaccine at Pfizer. Her work experience within outcomes research has been diverse and includes the design and conduct of prospective and retrospective observational studies, development of economic models, and the development of evidence dossiers. She earned her Doctor of Pharmacy degree at the University of Maryland, Baltimore. She then completed a pharmacoeconomics and outcomes research fellowship at Duke University and Novartis. She also holds a master’s and B.A. degree in Chemistry. She has co-authored over 30 peer-reviewed published papers, many on burden of disease, economic and humanistic value of pharmaceutical products in women’s health, infectious diseases, nephrology, and rheumatology.